Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes
Umberto Gianelli(University of Milan), Silvano Bòsari(Ospedale Maggiore), Maria Grazia Grimoldi(Ospedale Papa Giovanni XXIII), Guido Coggi(University of Milan), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Nicola Stefano Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Caterina Pellegrini(University of Milan), Federica Savi(University of Milan), Alessia Moro(AOL (United States))
Cited by 19
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553